BeStock  
Stocks › Medical Devices › KIDS

OrthoPediatrics KIDS

US equityMarket cap rank #3637Medical Devices
$22.48 −$0.23 (-1.01%)
Market closed · Oct 8, 7:00 am ET · Last extended-hours $22.26 -0.98%
Open$22.57
Prev close$22.71
Day range$22.42 – $22.91
Volume180.1K
Market cap$586.95M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$70.51M+15.4% YoY
Operating profit-$4.07M+47.1% YoY
Net profit-$7.16M-0.7% YoY
Diluted EPS-$0.30+0.0% YoY
Free cash flow-$3.12M+77.6% YoY
Operating cash flow$928,000.00

Revenue, last 8 quarters

$54.6MSep '24$52.7MDec '24$52.4MMar '25$61.1MJun '25$61.3MSep '25$61.6MDec '25$59.4MMar '26$70.5MJun '26

Net profit, last 8 quarters

$-7.9MSep '24$-16.1MDec '24$-10.7MMar '25$-7.1MJun '25$-11.8MSep '25$-10.1MDec '25$-10.7MMar '26$-7.2MJun '26

Diluted EPS by quarter

-0.34Sep '24-0.69Dec '24-0.46Mar '25-0.30Jun '25-0.50Sep '25-0.43Dec '25-0.45Mar '26-0.30Jun '26

Free cash flow by quarter

$-11.7MSep '24$-3.7MDec '24$-8.4MMar '25$-13.9MJun '25$-3.4MSep '25$9.7MDec '25$-5.0MMar '26$-3.1MJun '26

Annual revenue

$71.1MFY20$98.0MFY21$122.3MFY22$148.7MFY23$204.7MFY24$236.3MFY25

Profitability & balance sheet

Gross margin73.7%
Operating margin-9.0%
Net margin-15.7%
Return on equity-11.4%
Return on assets-7.8%
Return on invested capital-8.9%
Current ratio4.78
Liabilities / assets32.8%
Cash & investments$45.88M
Total debt$99.63M
Net cash (debt)-$53.75M

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Trauma and deformity$52.63M 74.6%
  • Scoliosis$16.88M 23.9%
  • Sports medicine/other$1.00M 1.4%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $70.51M $59.36M $236.35M $61.61M $61.25M
Total Operating Revenue $70.51M $59.36M $236.35M $61.61M $61.25M
Cost of Revenue $18.14M $15.97M $63.69M $16.50M $15.98M
Gross Profit $52.37M $43.39M $172.66M $45.11M $45.27M
Operating Expense $56.43M $51.73M $201.66M $50.61M $50.14M
Selling and Admin Expenses $54.11M $49.49M $192.56M $48.35M $47.81M
-Selling & Marketing Expense $21.29M $18.47M $72.73M $18.40M $18.65M
-General & Admin Expense $32.81M $31.02M $119.83M $29.95M $29.16M
Research & Development $2.33M $2.23M $9.10M $2.26M $2.33M
Operating Profit -$4.07M -$8.34M -$29.00M -$5.51M -$4.87M
Net Non-Operating Interest Income (Expense) -$2.53M -$2.10M -$6.00M -$1.93M -$1.82M
Non-Operating Interest Expense $2.53M $2.10M – – $1.82M
Other Income (Expense) -$334,000.00 -$421,000.00 -$4.19M -$2.33M -$5.21M
Special Income (Charges) -$1,000.00 $0.00 -$10.24M -$2.67M -$4.56M
-Less:Restructuring and Mergern & Acquisition $1,000.00 $0.00 $5.60M $296,000.00 $2.29M
Other Non-Operating Income (Expenses) -$333,000.00 -$421,000.00 $6.05M $341,000.00 -$648,000.00
Pretax Profit -$6.93M -$10.86M -$39.19M -$9.76M -$11.90M
Tax $234,000.00 -$171,000.00 $460,000.00 $340,000.00 -$125,000.00
Net Profit -$7.16M -$10.69M -$39.65M -$10.10M -$11.77M
Profit from Continuing Operations -$7.16M -$10.69M -$39.65M -$10.10M -$11.77M
Net Income to Parent Company -$7.16M -$10.69M -$39.65M -$10.10M -$11.77M
Net Income to Common Stockholders -$7.16M -$10.69M -$39.65M -$10.10M -$11.77M
Basic EPS -$0.30 -$0.45 -$1.69 -$0.43 -$0.50
Diluted EPS -$0.30 -$0.45 -$1.69 -$0.43 -$0.50
Total Other Finance Costs – – $6.00M – –
-Less:Impairment of Capital Assets – – $4.64M $2.37M $2.27M
Other Preferred Stock Dividends – – $0.00 – –

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $511.39M $502.19M $508.63M $508.63M $493.49M
Total Current Assets $252.51M $245.87M $256.42M $256.42M $245.85M
Cash and Cash Equivalents & Short-Term Investments $45.88M $48.81M $60.85M $60.85M $57.73M
-Cash and Cash Equivalents $17.00M $12.19M $19.56M $19.56M $16.83M
-Short Term Investments $28.88M $36.62M $41.30M $41.30M $40.90M
Receivables $60.95M $54.43M $53.84M $53.84M $51.27M
-Accounts Receivable $60.95M $54.43M $53.84M $53.84M $51.27M
Inventory $137.57M $134.02M $133.79M $133.79M $128.81M
Restricted Cash $2.05M $2.05M $2.06M $2.06M $2.06M
Other Current Assets $6.06M $6.55M $5.88M $5.88M $5.99M
Total Non-Current Assets $258.88M $256.32M $252.21M $252.21M $247.63M
Net PPE $48.55M $48.55M $49.56M $49.56M $51.20M
Goodwill and Other Intangible Assets $195.03M $191.89M $186.98M $186.98M $182.82M
-Goodwill $118.46M $115.17M $109.27M $109.27M $103.61M
-Other Intangible Assets $76.56M $76.72M $77.71M $77.71M $79.20M
Other Non-Current Assets $15.30M $15.88M $15.68M $15.68M $13.61M
Total Liabilities $167.77M $163.48M $162.03M $162.03M $144.18M
Total Current Liabilities $52.85M $47.18M $46.20M $46.20M $33.23M
Payables $23.34M $22.46M $20.98M $20.98M $8.35M
-Accounts Payable $22.24M $19.70M $18.79M $18.79M $7.16M
-Other Payable $1.10M $2.76M $2.19M $2.19M $1.18M
Short-Term Debt and Capital Lease Obligation $172,000.00 $172,000.00 $170,000.00 $170,000.00 $166,000.00
-Current Debt $172,000.00 $172,000.00 $170,000.00 $170,000.00 $166,000.00
Other Current Liabilities $13.75M $11.78M $11.35M $11.35M $10.90M
Total Non-Current Liabilities $114.92M $116.30M $115.84M $115.84M $110.95M
Long Term Accounts Payable and Other Payables $2.96M $2.96M $2.90M $2.90M $227,000.00
Long Term Debt and Capital Lease Obligation $99.46M $100.39M $99.82M $99.82M $99.17M
-Long Term Debt $99.46M $100.39M $99.82M $99.82M $99.17M
Non-Current Deferred Liabilities $3.31M $3.36M $3.58M $3.58M $3.80M
Other Non-Current Liabilities $9.19M $9.59M $9.54M $9.54M $7.74M
Total Equity $343.61M $338.71M $346.60M $346.60M $349.31M
Stockholders' Equity $343.61M $338.71M $346.60M $346.60M $349.31M
Capital Stock $7,000.00 $6,000.00 $6,000.00 $6,000.00 $6,000.00
-Common Stock $7,000.00 $6,000.00 $6,000.00 $6,000.00 $6,000.00
Additional Paid-In Capital $633.44M $626.01M $622.33M $622.33M $618.04M
Retained Earnings -$293.06M -$285.90M -$275.21M -$275.21M -$265.11M
Gains/Losses Not Affecting Retained Earnings $3.23M -$1.40M -$523,000.00 -$523,000.00 -$3.63M
-Gross PPE – – $107.42M $107.42M –
-Accumulated Depreciation – – -$57.87M -$57.87M –
Current Accrued Expenses – – $8.41M $8.41M –

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $928,000.00 -$3.29M -$4.85M $10.35M -$581,000.00
Net cash flow from continuing operations $928,000.00 -$3.29M -$4.85M $10.35M -$581,000.00
Net Income from Continuing Operations -$7.16M -$10.69M -$39.65M -$10.10M -$11.77M
Depreciation & Depletion & Amortization $5.71M $5.72M $21.12M $5.60M $5.30M
Deferred Tax $232,000.00 -$314,000.00 -$153,000.00 -$273,000.00 -$125,000.00
Other Non-Cash Items $259,000.00 $122,000.00 $333,000.00 $316,000.00 $19,000.00
Change in Working Capital -$2.30M -$2.11M -$10.79M $8.04M -$2.42M
-Change in Receivables -$6.35M -$183,000.00 -$9.37M -$1.10M $3.11M
-Change in Inventory -$2.69M $139,000.00 -$8.47M -$576,000.00 $1.01M
-Change in Prepaid Assets $684,000.00 -$483,000.00 $414,000.00 $238,000.00 $677,000.00
-Change in Payables and Accrued Expense $8.22M -$2.87M $9.42M $10.59M -$7.40M
-Change In Other Working Capital -$2.15M $1.28M -$2.79M -$1.11M $191,000.00
Net cash flow from investing $5.00M -$3.79M -$43.63M -$7.26M -$26.84M
Net Cash Flow from Continuing Investing Activities $5.00M -$3.79M -$43.63M -$7.26M -$26.84M
Net PPE Purchase and Sale -$4.05M -$1.76M -$11.11M -$599,000.00 -$2.84M
Net Business Purchase and Sale $1.13M -$6.78M -$15.50M -$6.65M -$8.53M
Net Investment Purchase and Sale $7.92M $4.75M -$17.02M -$10,000.00 -$15.47M
Financing Cash Flow -$737,000.00 -$614,000.00 $23.98M -$417,000.00 -$282,000.00
Net Cash Flow from Continuing Financing Activities -$737,000.00 -$614,000.00 $23.98M -$417,000.00 -$282,000.00
Net Issuance Payments Of Debt -$448,000.00 -$614,000.00 $24.84M $450,000.00 -$282,000.00
Ending Cash Balance $19.06M $14.25M $21.62M $21.62M $18.88M
Net Change in Cash $5.19M -$7.69M -$24.51M $2.67M -$27.70M
Beginning Cash Balance $14.25M $21.62M $45.78M $18.88M $46.61M
Effect of Exchange Rate Changes -$381,000.00 $313,000.00 $348,000.00 $64,000.00 -$20,000.00
Free Cash Flow -$3.12M -$5.05M -$15.96M $9.75M -$3.42M
Proceeds from Stock Option Exercised – – $0.00 – –
Net Other Financing Charges – – -$867,000.00 – –

Discussion

No comments yet — be the first to weigh in on KIDS.

Leave a comment

Scroll to Top